CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Total Rithm Capital Stockholders’ Equity	Preferred Stock	Common Stock	Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)	Accumulated Other Comprehensive Income	Noncontrolling Interests in Equity of Consolidated Subsidiaries
Preferred stock, shares outstanding, beginning balance (in shares) at Dec. 31, 2021			52,210,000,000
Common stock, shares outstanding beginning balance (in shares) at Dec. 31, 2021				466,758,266,000
Equity, beginning balance at Dec. 31, 2021	$ 6,669,380	$ 6,604,032	$ 1,262,481	$ 4,669	$ 6,059,671	$ (813,042)	$ 90,253	$ 65,348
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared on common stock	(116,697)	(116,697)				(116,697)
Dividends declared on preferred stock	(22,461)	(22,461)				(22,461)
Capital distributions	(8,879)							(8,879)
Preferred stock repurchase (in shares)			(171,658,000)
Preferred stock repurchase	(3,814)	(3,814)	$ (3,814)
Director share grants (in shares)				28,260,000
Director share grants	310	310			310
Comprehensive income (loss)
Net income (loss)	689,931	684,322				684,322		5,609
Unrealized gain (loss) on available-for-sale securities, net	(23,058)	(23,058)					(23,058)
Total comprehensive income (loss)	666,873	661,264						5,609
Preferred stock, shares outstanding, ending balance (in shares) at Mar. 31, 2022			52,038,342,000
Common stock, shares outstanding ending balance (in shares) at Mar. 31, 2022				466,786,526,000
Equity, ending balance at Mar. 31, 2022	$ 7,184,712	7,122,634	$ 1,258,667	$ 4,669	6,059,981	(267,878)	67,195	62,078
Preferred stock, shares outstanding, beginning balance (in shares) at Dec. 31, 2022	51,964,122		51,964,122,000
Common stock, shares outstanding beginning balance (in shares) at Dec. 31, 2022	473,715,100			473,715,100,000
Equity, beginning balance at Dec. 31, 2022	$ 7,010,068	6,943,001	$ 1,257,254	$ 4,739	6,062,019	(418,662)	37,651	67,067
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends declared on common stock	(120,754)	(120,754)				(120,754)
Dividends declared on preferred stock	(22,395)	(22,395)				(22,395)
Capital distributions	(5,430)							(5,430)
Cashless exercise of 2020 Warrants (in shares)				9,287,347,000
Cashless exercise of 2020 Warrants	0			$ 93	(93)
Director share grants and non-cash stock-based compensation (in shares)				15,300,000
Director share grants and non-cash stock-based compensation	125	125			125
Comprehensive income (loss)
Net income (loss)	89,949	91,249				91,249		(1,300)
Unrealized gain (loss) on available-for-sale securities, net	2,980	2,980					2,980
Total comprehensive income (loss)	$ 92,929	94,229						(1,300)
Preferred stock, shares outstanding, ending balance (in shares) at Mar. 31, 2023	51,964,122		51,964,122,000
Common stock, shares outstanding ending balance (in shares) at Mar. 31, 2023	483,017,747			483,017,747,000
Equity, ending balance at Mar. 31, 2023	$ 6,954,543	$ 6,894,206	$ 1,257,254	$ 4,832	$ 6,062,051	$ (470,562)	$ 40,631	$ 60,337